Abstract
Summary
Human skeletal muscle ho-mogenate has been shown to contain enzymes that catalyze the hydrolysis of L-leu-cyl p-nitroanilide and carbobenzoxygluta-myl-L-tyrosine, known substrates, respectively, for arylamidase and cathepsin A. The muscle arylamidase was found to be inhibited by p-chloromercuribenzoate. Addition of Co2+ resulted in slight stimulation of its activity. Neither ethylenediamine tetra-acetate nor thiol compounds had any appreciable effect on the enzyme. When compared to controls, no significant differences in muscle arylamidase levels were observed in patients with muscular dystrophies and certain selected neuromuscular diseases. Cathepsin A was, however, increased in muscles moderately affected by muscular dystrophy and denervating diseases.
Get full access to this article
View all access options for this article.
